95.99 Withdrawal of Standard Jul 7, 2022
ISO
ISO/TC 150/SC 2 Cardiovascular implants and extracorporeal systems
Technical Report
11.040.40 Implants for surgery, prosthetics and orthotics
ISO/TR 12417-2:2017 provides region-specific information for
- local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;
- changes related to the drug containing part and how they are evaluated by the different local regions.
For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
ISO/TR 12417-2:2017 is considered also as a supplement to ISO 12417‑1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. Requirements listed in this document also address VDDCPs that are not necessarily permanent implants.
WITHDRAWN
ISO/TR 12417-2:2017
95.99
Withdrawal of Standard
Jul 7, 2022
PUBLISHED
ISO/TR 12417-2:2022